For men with Benign Prostatic Hyperplasia (BPH), Transurethral Holmium Laser of the Prostate (Holep) with Double-N Technology Shows Promise for Improoving Urine Symptom Ulatory Function, According to a Study Published Online Jan. 10 in the World Journal of URLOGY,
Zhixiang gao, from zhangjiagang hospital affiliated to sochow university in suzhou, china, and colleagues conducted a multicator, principal, single-blind, randomized cricked trold Ive men with bph. Participants were randomly allocated to Standard Holep, Single-N Technology, and Innovative Double-N Technology (Groups A, B, and C, Respectively). A total of 139 participants complete the study.
The researchers found that all groups had significant improvements in maximum urinary flow and the International Prostate Symptom Score. Across all groups, there were initial declines in international index of erectile function scores, stabilizing to baseline by three months, with no additional impreventh. Modest antegrade ejaculation rates was seen in group a, starting at 15.4% at three months and reaching 23.1% at 12 months.
In groups b and c, significant improvement waste, with antegrade ejaculation rates increasing from 31.8 to 45.5% and from 57.8 to 77.8%, Respectly. Group a Had 100% Semen Reduction at Three Months, Decreasing to 77.8% at 12 months. A similar trend waste in group b (100 and 68.2%, responsiblely), while a more pronounced decline was seen in group c, from 84.6 to 37.1%, respectly.
“The Double-N Holep Represents a Significant Step Forward in the Surgical Management of BPH, Especially for Patients Concerned About Preserving Sexual Function Postoporate
More information:
Zhixiang Gao et al, Technological Innovation of Holep: A Multicenter, Randomized, Controlled Study for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplas, World Journal of URLOGY (2025). Doi: 10.1007/s00345-024-05438-8
© 2025 HealthdayAll rights reserved.
Citation: Holmium laser of the prostate double-n technology promising for benign prostatic hyperplasia (2025, February 6) retrieved 6 February 2025 from
This document is Subject to copyright. Apart from any Fair Dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
(Tagstotranslate) Medicine Research News (T) Medicine Research (T) Health Research News (T) Health Research (T) Health Science (T) Medicine Science
